Kimia Biosciences Limited Announces Resignation of Company Secretary & Compliance Officer

1 min read     Updated on 03 Apr 2026, 09:54 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kimia Biosciences Limited announced that Pallavi Garg (ACS 69848) has resigned from her position as Company Secretary & Compliance Officer effective April 03, 2026, due to personal reasons. The resignation will be formally considered by the Board of Directors in their upcoming meeting, and the company has complied with all regulatory disclosure requirements under SEBI regulations.

powered bylight_fuzz_icon
36779040

*this image is generated using AI for illustrative purposes only.

Kimia biosciences Limited has informed the stock exchanges about the resignation of its Company Secretary & Compliance Officer, marking a key managerial change at the pharmaceutical company.

Key Personnel Change

Pallavi Garg (ACS 69848) has tendered her resignation from the position of Company Secretary & Compliance Officer and Key Managerial Personnel of Kimia Biosciences Limited. The resignation was submitted through a formal letter dated April 03, 2026, citing personal reasons for her departure.

Parameter Details
Name Pallavi Garg
Membership Number ACS 69848
Position Company Secretary & Compliance Officer
Resignation Date April 03, 2026
Effective Date Close of business hours on April 03, 2026
Reason Personal reasons

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation letter will be presented to the Board of Directors during their next meeting for formal consideration and acceptance in accordance with applicable provisions.

Management Statement

The announcement was signed by Sameer Goel, Managing Director & CEO (DIN- 00161786), who confirmed that the resignation details have been shared with BSE Limited under scrip code 530313. The company has provided all required documentation, including the resignation letter as an enclosure to the regulatory filing.

Company Operations

Kimia Biosciences Limited operates from its registered office and works at Village Bhondsi, Damdama Lake Road, Gurugram, Haryana-122102, with its corporate office located at Aggarwal Millennium Tower-II, Netaji Subhash Place, Pitampura, New Delhi. The company will need to appoint a new Company Secretary & Compliance Officer to fulfill this key managerial position.

Historical Stock Returns for Kimia Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.42%-8.57%-22.77%-26.54%-37.50%-34.04%

How quickly will Kimia Biosciences appoint a replacement Company Secretary, and could any delays impact regulatory compliance or upcoming board decisions?

What potential challenges might the company face in maintaining governance standards during the transition period without a permanent compliance officer?

Could this resignation signal broader management instability at Kimia Biosciences, and are there any other key personnel changes expected?

Kimia Biosciences Shareholders Approve Managing Director Reappointment with 99.99% Majority

2 min read     Updated on 24 Mar 2026, 02:08 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kimia Biosciences Limited successfully completed its postal ballot for reappointing Mr. Sameer Goel as Managing Director, receiving 99.99% shareholder approval. Out of 35,789,738 total votes polled from 47,312,741 eligible shares, 35,786,742 votes supported the resolution. The e-voting process ran from February 20 to March 21, 2026, with results announced on March 23, 2026, demonstrating strong shareholder confidence in the company's leadership.

powered bylight_fuzz_icon
35843932

*this image is generated using AI for illustrative purposes only.

Kimia Biosciences Limited has successfully concluded its postal ballot process for the reappointment of Mr. Sameer Goel as Managing Director, with shareholders demonstrating overwhelming support for the resolution. The company announced the voting results on March 23, 2026, in compliance with SEBI regulations.

Voting Results and Shareholder Participation

The postal ballot achieved significant shareholder participation with comprehensive voting across different categories. The company had 12,783 total shareholders on the record date of February 06, 2026.

Category Shares Held Votes Polled Polling % Votes in Favor Votes Against Favor % Against %
Promoter and Promoter Group 35,455,808 35,455,776 99.9999% 35,455,776 0 100.00% 0%
Public Institutions 181,100 0 0% 0 0 0% 0%
Public Non-Institutions 11,675,833 333,962 2.8603% 330,966 2,996 99.1029% 0.8971%
Total 47,312,741 35,789,738 75.6450% 35,786,742 2,996 99.9916% 0.0084%

Resolution Details and Approval

The ordinary resolution for approving the reappointment of Mr. Sameer Goel as Managing Director received exceptional support from shareholders. The final voting summary showed remarkable consensus among participants.

Voting Outcome Valid Voters Valid Votes Percentage
Assent 191 35,786,742 99.99%
Dissent 9 2,996 0.01%
Total 200 35,789,738 100.00%

Postal Ballot Process and Timeline

The company conducted the postal ballot process entirely through e-voting in accordance with regulatory requirements. Key process milestones included:

  • Record Date: February 06, 2026
  • Scrutinizer Appointment: February 14, 2026
  • Notice Date: February 16, 2026
  • Notice Dispatch: February 18, 2026 (to 3,619 members via email)
  • Advertisement Publication: February 19, 2026 in Financial Express (English) and Jansatta (Hindi)
  • Voting Period: February 20, 2026 (9:00 AM IST) to March 21, 2026 (5:00 PM IST)
  • Results Declaration: March 23, 2026

Scrutinizer's Certification

CS Maghisuddin from M & CO. Company Secretaries served as the appointed scrutinizer for the postal ballot process. The scrutinizer confirmed that all votes cast by members were found to be valid after thorough examination. The report verified that the ordinary resolution was passed with the requisite majority as per statutory requirements.

Regulatory Compliance

The postal ballot was conducted in full compliance with Section 110 of the Companies Act, 2013, and the Companies (Management and Administration) Rules, 2014. The process also adhered to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with results being made available on the company's website and submitted to BSE Limited.

The successful completion of this postal ballot process demonstrates strong shareholder confidence in the company's leadership under Mr. Sameer Goel's continued guidance as Managing Director.

Historical Stock Returns for Kimia Biosciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.42%-8.57%-22.77%-26.54%-37.50%-34.04%

What strategic initiatives will Mr. Sameer Goel prioritize during his reappointed term as Managing Director?

How might the notably low institutional investor participation (0%) in the voting process impact future fundraising efforts?

Will Kimia Biosciences announce any major expansion plans or new product developments following this leadership continuity?

More News on Kimia Biosciences

1 Year Returns:-37.50%